Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATG9A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | AURKAIP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | FAM13A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | MAGED4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | DNALI1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | BAZ1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | MRPL50 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | FGA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | RPP40 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | TEX101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |